Influence of Tricuspid Valve Regurgitation on the short- and long-term survival after Transcatheter Aortic Valve Replacement (TAVR)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00022551

Enrollment

500

Registered

2020-09-17

Start date

2020-08-25

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I35.0 I07.1

Interventions

Group 1: To investigate the patients short-and long-term Survival (TAVI and Tricuspidregurgitation) no further investigations has to be proceeded. Only a retrostective Analysis from the institutional

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Aortic Stenosis and Tricuspid-Valve Insufficiency

Exclusion criteria

Exclusion criteria: no aortic Valve stenosis

Design outcomes

Primary

Measure	Time frame
1. Primary endpoint is defined as 30-day mortality. 2. this defined endpoint and further patients characteristics are routinely requested and sampled at the official institutional data base (registry)	—

Secondary

Measure	Time frame
long-term survival	—

Countries

Germany

Contacts

Public ContactThomas Puehler

University Medical Center Schleswig-HolsteinDpt. of Cardiac and Vascular Surgery

thomas.puehler@uksh.de+4043150022029

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026